These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 22137269

  • 1. Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats.
    Louis XL, Thandapilly SJ, MohanKumar SK, Yu L, Taylor CG, Zahradka P, Netticadan T.
    J Nutr Biochem; 2012 Sep; 23(9):1163-9. PubMed ID: 22137269
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
    Wang B, Sun J, Li X, Zhou Q, Bai J, Shi Y, Le G.
    Nutr Res; 2013 Nov; 33(11):971-81. PubMed ID: 24176237
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S, Fernández-Quintela A, Macarulla MT, Aguirre L, Hijona E, Bujanda L, Milagro F, Martínez JA, Portillo MP.
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [Abstract] [Full Text] [Related]

  • 5. Favorable effects of resveratrol on sympathetic neural remodeling in rats following myocardial infarction.
    Xin P, Pan Y, Zhu W, Huang S, Wei M, Chen C.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):293-300. PubMed ID: 20869962
    [Abstract] [Full Text] [Related]

  • 6. Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: therapeutic potential of resveratrol.
    Aubin MC, Lajoie C, Clément R, Gosselin H, Calderone A, Perrault LP.
    J Pharmacol Exp Ther; 2008 Jun 15; 325(3):961-8. PubMed ID: 18356487
    [Abstract] [Full Text] [Related]

  • 7. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb 15; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 8. Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity.
    Dobrian AD, Schriver SD, Lynch T, Prewitt RL.
    Am J Physiol Renal Physiol; 2003 Oct 15; 285(4):F619-28. PubMed ID: 12799306
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
    Franco JG, Lisboa PC, Lima NS, Amaral TA, Peixoto-Silva N, Resende AC, Oliveira E, Passos MC, Moura EG.
    J Nutr Biochem; 2013 Jun 15; 24(6):960-6. PubMed ID: 22959054
    [Abstract] [Full Text] [Related]

  • 10. Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice.
    Naowaboot J, Wannasiri S, Pannangpetch P.
    J Physiol Biochem; 2016 Jun 15; 72(2):269-80. PubMed ID: 26976296
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol toxicity: effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets.
    Rocha KK, Souza GA, Ebaid GX, Seiva FR, Cataneo AC, Novelli EL.
    Food Chem Toxicol; 2009 Jun 15; 47(6):1362-7. PubMed ID: 19298841
    [Abstract] [Full Text] [Related]

  • 12. [Oxidative stress and the susceptibility to obesity in rats].
    Liu X, Wang F, Li Y, Sun C.
    Wei Sheng Yan Jiu; 2011 Jul 15; 40(4):420-2. PubMed ID: 21861337
    [Abstract] [Full Text] [Related]

  • 13. Chronic treatment with resveratrol improves overactive bladder in obese mice via antioxidant activity.
    Alexandre EC, Calmasini FB, de Oliveira MG, Silva FH, da Silva CPV, André DM, Leonardo FC, Delbin MA, Antunes E.
    Eur J Pharmacol; 2016 Oct 05; 788():29-36. PubMed ID: 27316789
    [Abstract] [Full Text] [Related]

  • 14. The skeletal muscle Wnt pathway may modulate insulin resistance and muscle development in a diet-induced obese rat model.
    Zhou D, Strakovsky RS, Zhang X, Pan YX.
    Obesity (Silver Spring); 2012 Aug 05; 20(8):1577-84. PubMed ID: 22349736
    [Abstract] [Full Text] [Related]

  • 15. Sympathoinhibitory effects of telmisartan through the reduction of oxidative stress in the rostral ventrolateral medulla of obesity-induced hypertensive rats.
    Konno S, Hirooka Y, Kishi T, Sunagawa K.
    J Hypertens; 2012 Oct 05; 30(10):1992-9. PubMed ID: 22902874
    [Abstract] [Full Text] [Related]

  • 16. An intervention study in obese mice with astaxanthin, a marine carotenoid--effects on insulin signaling and pro-inflammatory cytokines.
    Arunkumar E, Bhuvaneswari S, Anuradha CV.
    Food Funct; 2012 Feb 05; 3(2):120-6. PubMed ID: 22089895
    [Abstract] [Full Text] [Related]

  • 17. Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice.
    Wang B, Sun J, Li L, Zheng J, Shi Y, Le G.
    Food Funct; 2014 Jul 25; 5(7):1452-63. PubMed ID: 24812660
    [Abstract] [Full Text] [Related]

  • 18. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice.
    Ludgero-Correia A, Aguila MB, Mandarim-de-Lacerda CA, Faria TS.
    Nutrition; 2012 Mar 25; 28(3):316-23. PubMed ID: 22079392
    [Abstract] [Full Text] [Related]

  • 19. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats.
    Rivera L, Morón R, Zarzuelo A, Galisteo M.
    Biochem Pharmacol; 2009 Mar 15; 77(6):1053-63. PubMed ID: 19100718
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular, metabolic, and coronary dysfunction in high-fat-fed obesity-resistant/prone rats.
    Dake BL, Oltman CL.
    Obesity (Silver Spring); 2015 Mar 15; 23(3):623-9. PubMed ID: 25645537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.